Stock listing
Mabion Sa
Selected listing: MAB · GPW · PLN · PL
Mabion Sa (GPW:MAB), Health Technology. Latest release Aug 26, 2026: Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune…
- Ticker
- GPW:MAB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- GPW
- Currency
- PLN
About Mabion Sa
Mabion Sa is a public company listed on the Polish market under the ticker MAB. Mabion focuses on biopharmaceuticals and aims to develop innovative therapies to address unmet medical needs.
Latest news from Mabion Sa
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
August 26, 2026
Mabion S A : Other information to the quarterly report of Mabion S.A. for Q1 2026
May 19, 2026
Mabion S A : Interim condensed financial statements for the 3-month period ended 31 March 2026
May 19, 2026
Mabion S A : Financial statements for the financial year ended 31 December 2025
April 29, 2026
Mabion S A : Presentation of financial results for FY 2025 – Mabion
April 28, 2026
Research Mabion Sa
Alternate listings
272:GETTEX
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.
0QGW:LSE
GB · PLN
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.
A1J13Q:LSX
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.
A1J13Q:LS
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.
272:SWB
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.
272:FWB
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.
272:MUN
DE · EUR
Alternate listing for Mabion Sa; the primary context on this page is MAB:GPW.